PGC-1α Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study
暂无分享,去创建一个
Ekta Rai | A. Bhat | R. Bamezai | Swarkar Sharma | E. Rai | A. Koul | M. Dhar | Anil Koul | Audesh Bhat | Swarkar Sharma | M. K. Dhar | R. N. K. Bamezai | Anil Koul | Manoj K. Dhar | Ramesh Bamezai
[1] T. Kadowaki,et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes , 2002, Diabetologia.
[2] P. Puigserver,et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] F. Krempler,et al. Role of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α in the Transcriptional Regulation of the Human Uncoupling Protein 2 Gene in INS-1E Cells , 2006 .
[4] P. Puigserver,et al. Suppression of β Cell Energy Metabolism and Insulin Release by PGC-1α , 2003 .
[5] V. Mohan,et al. Peroxisome proliferator‐activated receptor‐γ co‐activator‐1α (PGC‐1α) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[6] S. O’Rahilly,et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes , 2006, Diabetologia.
[7] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[8] P. Puigserver,et al. A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.
[9] C. Bogardus,et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. , 2000, The Journal of clinical investigation.
[10] Guillaume Adelmant,et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.
[11] Dimitri Krainc,et al. Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration , 2006, Cell.
[12] K. Darvishi,et al. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. , 2007, Cancer letters.
[13] Y. Pak,et al. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. , 2006, Biochemical and biophysical research communications.
[14] T. Hansen,et al. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus , 2001, Diabetologia.
[15] P. Boutin,et al. No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasians. , 2002, Diabetologia.
[16] B. Lowell,et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. , 2001, Cell.
[17] M. Vohl,et al. Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome. , 2005, Molecular genetics and metabolism.
[18] P Katajisto,et al. Mutation analysis of three genes encoding novel LKB1-interacting proteins, BRG1, STRADα, and MO25α, in Peutz–Jeghers syndrome , 2005, British Journal of Cancer.
[19] F. Gonzalez,et al. The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4α and cAMP-response Element-binding Protein (CREB)* , 2002, The Journal of Biological Chemistry.
[20] A. Bhat,et al. The possible role of 10398A and 16189C mtDNA variants in providing susceptibility toT2DM in two North Indian populations: a replicative study , 2007, Human Genetics.
[21] P. Puigserver,et al. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. , 2000, Molecular cell.
[22] Y. Pak,et al. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) on mitochondrial transcription factor A (Tfam) promoter , 2006 .
[23] I. Férnandez-Cadenas,et al. Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease , 2003, Neurology.
[24] Derek Middleton,et al. Mitochondrial DNA polymorphism: its role in longevity of the Irish population , 2001, Experimental Gerontology.
[25] F. Krempler,et al. Role of peroxisome proliferator-activated receptor-gamma coactivator-1alpha in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells. , 2006, Endocrinology.
[26] F. Leonetti,et al. The Gly482Ser Missense Mutation of the Peroxisome Proliferator-Activated Receptor γ Coactivator-1α (PGC-1α) Gene Associates with Reduced Insulin Sensitivity in Normal and Glucose-Intolerant Obese Subjects , 2006, Disease markers.
[27] Young-Bum Kim,et al. Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes , 2001, Cell.
[28] E. Lander,et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.
[29] P. Puigserver,et al. Suppression of beta cell energy metabolism and insulin release by PGC-1alpha. , 2003, Developmental cell.
[30] P. Haslinger,et al. Peroxisome Proliferator-Activated REceptor γ Coactivator-1α Gene Variations Are Not Associated With Gestational Diabetes Mellitus , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[31] Jiandie D. Lin,et al. Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators , 2006, Cell.